Refine by
Diagnostic Tool Development Suppliers Serving Congo
118 companies found
based inSalem, NEW HAMPSHIRE (USA)
We've manufactured over 8 million devices, three billion sensors, and developed the first FDA-cleared blood glucose meter/app for iPhone®. We've been featured by the New York Times and Fast Company, and work with some of the world's largest ...
based inHuesca, SPAIN
Vitassay develops and distributes reliable and certified solutions for the early detection of different pathogens which cause infectious diseases in humans. Our greatest asset is to offer a complete service for every customer to exceed their ...
based inReeuwijk, NETHERLANDS
BioChek provides an accurate, reliable and easy-to-use animal health monitoring system for the Poultry and Swine industry, and associated diagnostic solutions for Food Safety testing. This system consists of a broad range of ELISA and PCR test kits, ...
based inShenzhen, CHINA
Aikang MedTech Co., Ltd. was founded in 2003, is a high-tech enterprise specializing in medical equipment and in vitro diagnostic reagents product, integrating production, sales and after-sales service. Aikang has four platforms of ELISA analyzer, ...
based inVienna, AUSTRIA
We are specialized in biomarker development using blood-circulating microRNAs – evolutionary conserved regulators of gene expression and cell/tissue function. We develop diagnostic algorithms (“signatures”) based on the logic combination of microRNA ...
based inTucson, ARIZONA (USA)
Accelerate Diagnostics, Inc. is an in vitro diagnostics company dedicated to providing solutions for the global challenge of antibiotic resistance and hospital acquired infections. Established in 1987, the company began research activity for ...
based inBensheim, GERMANY
We specialise in the development and production of innovative parameters and detection methods for laboratory diagnostics and medical research. Our focus is the development of immunological detection methods for unoccupied niches. The products from ...
based inCarlsbad, CALIFORNIA (USA)
DCN Dx, based in Carlsbad, California, is a global leader in IVD CDMO and CRO services, including clinical trials and regulatory services, specializing in the development of custom assays, consumables, and instruments for point-of-use applications. ...
based inFramingham, MASSACHUSETTS (USA)
Kephera Diagnostics is a startup that aims to address the public health challenges of global infectious diseases with point of care assay technology. We collaborate with a global community of researchers to develop and translate new technologies ...
based inKävlinge, SWEDEN
The Genovis Group consists of Genovis AB, Sweden, and the wholly owned subsidiary Genovis Inc., USA. The company's shares are listed on Nasdaq First North Growth Market. Genovis’ business concept is to offer customers in the biopharmaceutical and ...
based inMonmouth Junction, NEW JERSEY (USA)
DiamiR is a privately held molecular diagnostics company focused on developing minimally invasive tests for detection and monitoring of pathology based on quantitative analysis of organ-enriched microRNA signatures in plasma for screening, patient ...
based inWest Lafayette, INDIANA (USA)
Tymora Analytical Operations provides diagnostic development and exosome proteomics contract services and products for improved cancer research. Tymora’s primary goal is to enable the shift from tissue to liquid biopsy. Our new technologies allow ...
based inHayward, CALIFORNIA (USA)
Novodiax is dedicated to advancing tissue-based diagnostics and immunoassays through innovation. Our signature technology platform is a proprietary polymer-based detection system. Based on this technology we have developed a series of highly ...
Use the Novodiax polymerized horseradish peroxidase (polyHRP) signal amplification technology (ihcDirect) and conjugate it directly to your humanized antibody-of-choice to enable rapid, sensitive IHC testing. Jumpstart your early humanized ...
based inOak Brook, ILLINOIS (USA)
Inspired by a friendly wager with a colleague while at a scientific conference, Horry Jones, M.D, Ph.D., successfully developed the “Metabolimeter”, the first waterless Basal Metabolism Test instrument. This significant development led to the ...
based inIrvine, CALIFORNIA (USA)
Konan Medical develops and distributes innovative ophthalmic diagnostic devices that help clinicians diagnose and manage vision- threatening or potentially life-threatening disorders. Konan Medical USA is an ISO 13485, FDA Registered, MDSAP ...
based inValladolid, SPAIN
Founded in 2010, AMADIX is a leading molecular diagnostics company, focused on liquid biopsy, developing innovative diagnostic tests for early cancer detection in blood. Our mission is to extend people’s lives by developing disruptive technologies ...
based inHangzhou City, CHINA
Cnpair Biotech Co., Ltd. is a professional provider which concentrates on IVD core materials, including antibodies and proteins, and we are dedicated to developing and delivering highly competitive antibodies and proteins with outstanding ...
based inNew York, NEW YORK (USA)
Acuamark Diagnostics develops technology which allows for highly accurate screening of blood to detect cancer markers at the early cancer stages, before the cancer becomes untreatable. Backed by a highly experienced team of scientific and business ...
based inBurnaby, BRITISH COLUMBIA (CANADA)
Fusion Genomics is a Vancouver-based company that is advancing molecular diagnostics by developing identification tests for pathogens using proprietary technologies in combination with Next Generation Sequencing. Our ONETest products, in combination ...
based inNottingham, UNITED KINGDOM
Oncimmune is a leading immuno diagnostics developer, primarily focused on the growing fields of immuno-oncology, autoimmune disease and infectious diseases. Our growing range of diagnostic products can detect early-stage cancer and our service-based ...
Oncimmune’s proprietary biomarker discovery engine, which is leveraged in our ImmunoINSIGHTS services to discover and validate novel biomarkers that can help stratify patients in multiple cancer indications and with different autoimmune ...
